Clinical Trial Update: Pharmacokinetics of Low Dose Ritonavir [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 pharmacokinetics study of low-dose ritonavir in HIV infection has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Norvir (ritonavir)

Snippet

Sponsor: The HIV Netherlands Australia Thailand Research Collaboration | Conditions: HIV Infections | Phase 1, Phase 2 | Status: COMPLETED